Justin Roberts
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Professor of Nutritional Physiology
Also affiliated: Dalhousie University (2013); University of Minnesota (2013–2014); Lehigh Valley Hospital-Pocono (2011–2013); University of Hertfordshire (2010–2016); University of Bedfordshire (2016); Providence College (2020); Centre for Social Innovation (2026); New England College of Optometry (2020); Good Samaritan Medical Center (2015–2016); Somerset County Council (1998); Santa Clara Valley Medical Center (2012); Northwick Park Hospital (1997); Lancaster General Hospital (2014–2024); Providence VA Medical Center (2020); Danone (France) (2026); Qatar Orthopaedic and Sports Medicine Hospital (2016); Banner - University Medical Center Phoenix (2015); Danone (Netherlands) (2023–2026); Valley Medical Center (2012); Taunton & Somerset NHS Foundation Trust (1998); University of Pennsylvania Health System (2016–2024); Nutricia Research (Netherlands) (2023); Danone Nutricia Research (Netherlands) (2023); Anglia Ruskin University (2015–2026); Qatar University (2016); University of Pennsylvania (2011); Auburn University (2018)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Justin Roberts investigates physiological responses to exercise and nutrition, with a focus on endurance performance and metabolic health. His work examines factors influencing fat oxidation, body composition, and cardio-metabolic markers in various populations, including overweight adults and athletes. Roberts has explored the impact of dietary supplements, such as decaffeinated green tea extract and carbohydrate intake, on physiological outcomes. His research also delves into the role of the gut microbiome in athletic performance and the genetic underpinnings of fitness.
Further research by Roberts addresses sex differences in ultra-endurance sports and the identification of novel inflammatory biomarkers for cardiovascular risk in young individuals. He has conducted systematic reviews and meta-analyses on topics including the effects of protein supplementation on exercise adaptations and the influence of exercise-associated genes on fitness components. His publications also include a review on vitamin D levels in different ethnic groups and their implications during the COVID-19 pandemic.
Roberts is a professor at Arkansas State University and leads a research group. His scholarly contributions are recognized by a high-impact researcher designation, evidenced by an h-index of 25 and over 2,250 citations across his 196 publications. He collaborates with researchers at Arkansas State University, including Mohammad A. Alam, Robert C. Shields, Subrata Roy, and David F. Gilmore.
Metrics
- h-index: 25
- Publications: 197
- Citations: 2,278
Selected Publications
-
Design, Synthesis, and Development of 4-[2-[3,5-Bis(trifluoromethyl)anilino]thiazolo-4-yl]phenol as a Dual Inhibitor of Fatty Acid Biosynthesis (FASII) to Clear MRSA Infection (2026)
-
Construction of an arrayed CRISPRi library as a resource for essential gene function studies in <i>Streptococcus mutans</i> (2023)
-
Development and Antibacterial Properties of 4-[4-(Anilinomethyl)-3-phenylpyrazol-1-yl]benzoic Acid Derivatives as Fatty Acid Biosynthesis Inhibitors (2023)
Collaboration Network
Top Collaborators
- Development and Antibacterial Properties of 4-[4-(Anilinomethyl)-3-phenylpyrazol-1-yl]benzoic Acid Derivatives as Fatty Acid Biosynthesis Inhibitors
- Construction of an arrayed CRISPRi library as a resource for essential gene function studies in <i>Streptococcus mutans</i>
- Development and Antibacterial Properties of 4-[4-(Anilinomethyl)-3-phenylpyrazol-1-yl]benzoic Acid Derivatives as Fatty Acid Biosynthesis Inhibitors
- Construction of an arrayed CRISPRi library as a resource for essential gene function studies in <i>Streptococcus mutans</i>
- Development and Antibacterial Properties of 4-[4-(Anilinomethyl)-3-phenylpyrazol-1-yl]benzoic Acid Derivatives as Fatty Acid Biosynthesis Inhibitors
- Development and Antibacterial Properties of 4-[4-(Anilinomethyl)-3-phenylpyrazol-1-yl]benzoic Acid Derivatives as Fatty Acid Biosynthesis Inhibitors
- Development and Antibacterial Properties of 4-[4-(Anilinomethyl)-3-phenylpyrazol-1-yl]benzoic Acid Derivatives as Fatty Acid Biosynthesis Inhibitors
- Development and Antibacterial Properties of 4-[4-(Anilinomethyl)-3-phenylpyrazol-1-yl]benzoic Acid Derivatives as Fatty Acid Biosynthesis Inhibitors
- Construction of an arrayed CRISPRi library as a resource for essential gene function studies in <i>Streptococcus mutans</i>
Similar Researchers
Based on overlapping research topics